“It’s just a clear watering down of the original bill,” said retired Army Col. Vic Suarez, a former medical supply-chain commander who has been leading a push for more domestic pharmaceutical manufacturing.
He and others also questioned why drug companies need multiple years to comply…
ProPublica tested several versions of widely prescribed generic drugs and found two samples with irregularities that experts say could compromise their effectiveness…
The problem is that the generic drug system is built to be fragile. Manufacturers compete against one another for orders from price-conscious health care providers, cutting costs where they can to offer the lowest prices. This leads to a race to the bottom of minimum accepted standards, including a lack of investment in quality systems and limited redundancy...
A small but growing number of "cash" pharmacies take no insurance, instead selling generic drugs, often at far lower prices than customers pay with insurance...
California wants to become the first state to create its own prescription drug label, Gov. Gavin Newsom (D) announced Thursday morning.
As part of his 2020-2021 budget, Newsom wants to create the first-ever state generic drug label as part of a series of sweeping proposals designed to lower the cost of health care in the Golden State. He also wants public and private insurers to negotiate drug prices together to leverage lower prices..... https://thehill.com/policy/healthcare/477494-california-plans-to-launch-own-prescription-drug-label
Generic drugs amount to 90% of all prescriptions filled in the U.S., most of them made in plants in India and China. Generic drugs can be more affordable, but in her new explosive book “Bottle of Lies: The Inside Story of the Generic Drug Boom,” investigative journalist Katherine Eban works with two industry whistleblowers to expose how some manufacturers are cutting corners at the cost of quality and safety. This comes as the U.S. Food and Drug Administration just issued its own update on the state of pharmaceutical quality that found the drug quality of factories in India and China scored below the world average. FDA officials say that’s because more robust inspections have uncovered problems and that “the quality of the drug supply has never been higher.” ...
Interview: https://youtu.be/lCrTuT5ywvI
:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/65050291/GettyImages_1308067.0.jpg)
